Viewing Study NCT05251792


Ignite Creation Date: 2025-12-24 @ 3:58 PM
Ignite Modification Date: 2026-02-01 @ 10:52 AM
Study NCT ID: NCT05251792
Status: UNKNOWN
Last Update Posted: 2023-02-13
First Post: 2022-02-11
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Macular Pigment Optical Density in Primary Angle-closure Disease
Sponsor: Zhongshan Ophthalmic Center, Sun Yat-sen University
Organization:

Study Overview

Official Title: Study on the Relationship Between Macular Pigment Optical Density and Primary Angle-closure Disease
Status: UNKNOWN
Status Verified Date: 2022-02
Last Known Status: RECRUITING
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: Glaucoma is the leading cause of irreversible blindness in the world, and primary angle-closure glaucoma (PACG) is the most important type of glaucoma in Asia. Primary angle closure disease (PACD) is a group of diseases related to PACG, and the pathogenesis is still unclear. Macular pigment has the functions of filtering short-wavelength waves and anti-oxidation, which are related to visual function. Previous studies have found that the macular pigment density (MPOD) is significantly reduced in primary open-angle glaucoma. This project uses the single-wavelength reflection method to measure MPOD, observes the characteristics of PACD and the normal control group's changes in retinal MPOD, and explains the relationship between PACD's MPOD changes and angle-closure glaucoma optic nerve damage
Detailed Description: Observation index: Visual acuity,Intraocular pressure,Ophthalmoscope,MPOD,Visual field and OCT.

Inspection parameters of OCT:

1. Retinal nerve fiber layer thickness
2. Ganglion cell complex thickness
3. Mean thickness of the central retina
4. Mean defect

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: